Loading...
HEAL logo

S.C. Helios S.A.BVB:HEAL Stock Report

Market Cap RON 34.7m
Share Price
n/a
1Y42.9%
7D0%
1D0%
Portfolio Value
View

S.C. Helios S.A.

BVB:HEAL Stock Report

Market Cap: RON 34.7m

S.C. Helios (HEAL) Stock Overview

Engages in the fabrication of refractory materials in Romania. More details

HEAL fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends0/6

HEAL Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW489,733 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
AG
Agricola
489,733 investors already sharing narratives

S.C. Helios S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for S.C. Helios
Historical stock prices
Current Share PriceRON 24.00
52 Week HighRON 25.80
52 Week LowRON 15.00
Beta0.32
1 Month Change-6.98%
3 Month Change4.35%
1 Year Change42.86%
3 Year Changen/a
5 Year Changen/a
Change since IPO1,500.00%

Recent News & Updates

Recent updates

Analysis Article Nov 21

Even With A 33% Surge, Cautious Investors Are Not Rewarding S.C. Helios S.A.'s (BVB:HEAL) Performance Completely

S.C. Helios S.A. ( BVB:HEAL ) shareholders have had their patience rewarded with a 33% share price jump in the last...
Analysis Article Nov 12

We Like These Underlying Return On Capital Trends At S.C. Helios (BVB:HEAL)

There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...
Analysis Article Oct 07

S.C. Helios S.A.'s (BVB:HEAL) Price Is Right But Growth Is Lacking After Shares Rocket 30%

S.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...
Analysis Article Oct 07

S.C. Helios S.A. (BVB:HEAL) Held Back By Insufficient Growth Even After Shares Climb 30%

S.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...
Analysis Article Jun 12

S.C. Helios (BVB:HEAL) Is Experiencing Growth In Returns On Capital

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article Apr 26

Further Upside For S.C. Helios S.A. (BVB:HEAL) Shares Could Introduce Price Risks After 29% Bounce

Those holding S.C. Helios S.A. ( BVB:HEAL ) shares would be relieved that the share price has rebounded 29% in the last...
Analysis Article Apr 21

S.C. Helios (BVB:HEAL) Seems To Use Debt Rather Sparingly

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article Feb 25

Take Care Before Jumping Onto S.C. Helios S.A. (BVB:HEAL) Even Though It's 25% Cheaper

The S.C. Helios S.A. ( BVB:HEAL ) share price has fared very poorly over the last month, falling by a substantial 25...
Analysis Article Dec 30

S.C. Helios S.A. (BVB:HEAL) Stock Rockets 29% But Many Are Still Ignoring The Company

S.C. Helios S.A. ( BVB:HEAL ) shares have had a really impressive month, gaining 29% after a shaky period beforehand...
Analysis Article Nov 10

S.C. Helios S.A. (BVB:HEAL) Stock Rockets 192% But Many Are Still Ignoring The Company

S.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...
Analysis Article Nov 03

S.C. Helios (BVB:HEAL) Has A Rock Solid Balance Sheet

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Analysis Article Sep 03

A Piece Of The Puzzle Missing From S.C. Helios S.A.'s (BVB:HEAL) Share Price

With a price-to-earnings (or "P/E") ratio of 4.8x S.C. Helios S.A. ( BVB:HEAL ) may be sending very bullish signals at...
Analysis Article May 21

Not Many Are Piling Into S.C. Helios S.A. (BVB:HEAL) Stock Yet As It Plummets 27%

S.C. Helios S.A. ( BVB:HEAL ) shareholders that were waiting for something to happen have been dealt a blow with a 27...

Shareholder Returns

HEALRO Basic MaterialsRO Market
7D0%-1.2%0.1%
1Y42.9%-2.9%73.1%

Return vs Industry: HEAL exceeded the RO Basic Materials industry which returned -2.9% over the past year.

Return vs Market: HEAL underperformed the RO Market which returned 70.9% over the past year.

Price Volatility

Is HEAL's price volatile compared to industry and market?
HEAL volatility
HEAL Average Weekly Movementn/a
Basic Materials Industry Average Movement4.8%
Market Average Movement4.9%
10% most volatile stocks in RO Market12.4%
10% least volatile stocks in RO Market2.7%

Stable Share Price: HEAL's share price has been volatile over the past 3 months compared to the RO market.

Volatility Over Time: Insufficient data to determine HEAL's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
199164Dorel Cobarzanwww.heliossa.ro

S.C. Helios S.A. engages in the fabrication of refractory materials in Romania. The company offers refractory brick, short and long wedge type refractory brick, anti-acid refractory tubing, and refractory mortar; mortar; anti-acid refractory products, tiles, tile plywood, brick, and tubing; construction materials, including red brick, construction, efficient brick, ornamental brick for fences; and decorative products, such as ceramic plywood. It also provides ovens decorative products, including ceramic veneer; and ovens and grill, smoke chimney systems, ducting acid-resistant refractory, outer casing, and chimney.

S.C. Helios S.A. Fundamentals Summary

How do S.C. Helios's earnings and revenue compare to its market cap?
HEAL fundamental statistics
Market capRON 34.73m
Earnings (TTM)RON 5.52m
Revenue (TTM)RON 31.62m
6.3x
P/E Ratio
1.1x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HEAL income statement (TTM)
RevenueRON 31.62m
Cost of RevenueRON 9.13m
Gross ProfitRON 22.49m
Other ExpensesRON 16.97m
EarningsRON 5.52m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

Aug 27, 2026

Earnings per share (EPS)3.81
Gross Margin71.12%
Net Profit Margin17.45%
Debt/Equity Ratio17.4%

How did HEAL perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/10 06:21
End of Day Share Price 2026/07/03 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

S.C. Helios S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.